Skip to main content
Top
Published in: Annals of Surgical Oncology 4/2010

01-04-2010 | Thoracic Oncology

Radiofrequency Ablation (RFA) of Pulmonary Metastases: Technical Success vs. Actual Benefit

Author: Frank C. Detterbeck, MD

Published in: Annals of Surgical Oncology | Issue 4/2010

Login to get access

Excerpt

I was both excited and disturbed as I read the article by Huo about RFA of pulmonary metastases.1 I’m excited for patients because this article adds data on the technical success of RFA of pulmonary metastases. However, as someone devoted to evidence-based care, the lack of attention to the appropriateness of treatment in the first place is disturbing. …
Literature
1.
go back to reference Huo ASY, Morris DL, King J, Glenn D. Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma. Ann Surg Oncol. 2009;16:3169–75.CrossRef Huo ASY, Morris DL, King J, Glenn D. Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma. Ann Surg Oncol. 2009;16:3169–75.CrossRef
2.
go back to reference Aberg T, Malmberg KA, Nilsson B, Nöu E. The effect of metastasectomy: fact or fiction? Ann Thorac Surg. 1980;4:378–84.CrossRef Aberg T, Malmberg KA, Nilsson B, Nöu E. The effect of metastasectomy: fact or fiction? Ann Thorac Surg. 1980;4:378–84.CrossRef
Metadata
Title
Radiofrequency Ablation (RFA) of Pulmonary Metastases: Technical Success vs. Actual Benefit
Author
Frank C. Detterbeck, MD
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 4/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0905-7

Other articles of this Issue 4/2010

Annals of Surgical Oncology 4/2010 Go to the issue